These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20011659)

  • 1. Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors.
    Davies MN; Bayry J; Tchilian EZ; Vani J; Shaila MS; Forbes EK; Draper SJ; Beverley PC; Tough DF; Flower DR
    PLoS One; 2009 Nov; 4(11):e8084. PubMed ID: 20011659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.
    Bayry J; Tchilian EZ; Davies MN; Forbes EK; Draper SJ; Kaveri SV; Hill AV; Kazatchkine MD; Beverley PC; Flower DR; Tough DF
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10221-6. PubMed ID: 18621704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Adjuvant Design and Validation.
    Davies MN; Pere H; Bosschem I; Haesebrouck F; Flahou B; Tartour E; Flower DR; Tough DF; Bayry J
    Methods Mol Biol; 2017; 1494():107-125. PubMed ID: 27718189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CCR4 antagonist enhances DC activation and homing to the regional lymph node and shows potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment.
    Yamamoto S; Matsuo K; Nagakubo D; Higashiyama S; Nishiwaki K; Oiso N; Kawada A; Yoshie O; Nakayama T
    J Pharmacol Sci; 2018 Mar; 136(3):165-171. PubMed ID: 29519579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens.
    Pere H; Montier Y; Bayry J; Quintin-Colonna F; Merillon N; Dransart E; Badoual C; Gey A; Ravel P; Marcheteau E; Batteux F; Sandoval F; Adotevi O; Chiu C; Garcia S; Tanchot C; Lone YC; Ferreira LC; Nelson BH; Hanahan D; Fridman WH; Johannes L; Tartour E
    Blood; 2011 Nov; 118(18):4853-62. PubMed ID: 21908423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Molecule CCR4 Antagonists Protect Mice from
    Bozza S; Iannitti RG; Pariano M; Renga G; Costantini C; Romani L; Bayry J
    Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33669094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.
    Hagemann UB; Gunnarsson L; Géraudie S; Scheffler U; Griep RA; Reiersen H; Duncan AR; Kiprijanov SM
    PLoS One; 2014; 9(7):e103776. PubMed ID: 25080123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma.
    Sun W; Li WJ; Wei FQ; Wong TS; Lei WB; Zhu XL; Li J; Wen WP
    Oncotarget; 2016 Jun; 7(25):37714-37727. PubMed ID: 27177223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualizing CD4 T-cell migration into inflamed skin and its inhibition by CCR4/CCR10 blockades using in vivo imaging model.
    Wang X; Fujita M; Prado R; Tousson A; Hsu HC; Schottelius A; Kelly DR; Yang PA; Wu Q; Chen J; Xu H; Elmets CA; Mountz JD; Edwards CK
    Br J Dermatol; 2010 Mar; 162(3):487-96. PubMed ID: 19832835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues.
    Panek WK; Toedebusch RG; Mclaughlin BE; Dickinson PJ; Van Dyke JE; Woolard KD; Berens ME; Lesniak MS; Sturges BK; Vernau KM; Li C; Miska J; Toedebusch CM
    J Neurooncol; 2024 Sep; 169(3):647-658. PubMed ID: 39046599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
    Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
    J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.
    Ajram L; Begg M; Slack R; Cryan J; Hall D; Hodgson S; Ford A; Barnes A; Swieboda D; Mousnier A; Solari R
    Eur J Pharmacol; 2014 Apr; 729(100):75-85. PubMed ID: 24534492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells.
    Iellem A; Colantonio L; D'Ambrosio D
    Eur J Immunol; 2003 Jun; 33(6):1488-96. PubMed ID: 12778466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct functions of CXCR3
    Yu S; Shen J; Lao S; Yang B; Wu C
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1514-1522. PubMed ID: 30606326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy.
    Beziaud L; Boullerot L; Tran T; Mansi L; Marie-Joseph EL; Ravel P; Johannes L; Bayry J; Tartour E; Adotévi O
    Int J Cancer; 2018 Dec; 143(11):3008-3018. PubMed ID: 30183073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of thiourea derivatives and carbonyl-2-aminothiazole derivatives for potential CCR4 antagonists using capillary zone electrophoresis.
    Zhang S; Qi H; Yakufu P; Zhao F; Ling X; Xiao J; Wang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):75-82. PubMed ID: 21144808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 alters migration capacity of CD4
    He S; Xue M; Cai G
    Scand J Immunol; 2021 Nov; 94(5):e13099. PubMed ID: 34940981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower numbers of FoxP3 and CCR4 co-expressing cells in an elevated subpopulation of CD4+CD25high regulatory T cells from Wegener's granulomatosis.
    Klapa S; Mueller A; Csernok E; Fagin U; Klenerman P; Holl-Ulrich K; Gross WL; Lamprecht P
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):72-80. PubMed ID: 20412707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer.
    Maeda S; Murakami K; Inoue A; Yonezawa T; Matsuki N
    Cancer Immunol Res; 2019 Jul; 7(7):1175-1187. PubMed ID: 31160277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.